Estrogen receptor-negative breast ductal carcinoma: clinicopathological features and MIB-1 (Ki-67) proliferative index association.
Breast cancer estrogen receptor (ER) status is one of the strong additional factors in predicting response of patients towards hormonal treatment. The main aim of this study was to assess the morphological characteristics and proliferative activity using MIB-1(Ki-67) of estrogen receptor negative in...
Saved in:
| Main Authors: | Noorasmaliza Mdpaiman, Siti Aishah Md Ali, Reena Mdzin, Meor Zamari Meor Kamal, Wan Anna Md Amin, Mohan Nallusamy, Pavitratha Puspanathan, Rohaizak Muhammad, Sharifa Ezat Wan Puteh, Srijit Das |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0089172&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Proliferative activity of myeloma cells determined by Ki-67 antibody: Biological and clinical significance
by: Marković Olivera, et al.
Published: (2005-01-01) -
Association of the Estrogen Receptors Beta Expression with the Ki-67 Proliferative Index in Breast Cancer
by: T. A. Bogush, et al.
Published: (2023-07-01) -
Ki-67 and MCM-2 in Dental Follicle and Odontogenic Cysts: The Effects of Inflammation on Proliferative Markers
by: Nurhan Güler, et al.
Published: (2012-01-01) -
Agreement between Ki-67 Proliferative Index in Breast Cancer by Conventional Hotspot Method and International Ki-67 in Breast Cancer Working Group Global Scoring Method: A Cross-sectional Study
by: Nidhi Radhakrishnan, et al.
Published: (2024-12-01) -
Predictive value of morphological features and proliferative markers (mitotic index, Ki-67, PHH3) in bronchopulmonary neuroendocrine tumors
by: L. M. Zakhartseva, et al.
Published: (2021-12-01)